
    
      30 patients with stable angiographically documented coronary artery disease will be
      randomized to receive olive extracts with high concentration of hydroxytyrosol (10 mg po
      twice per day included in Olivomed capsules) or placebo for three months and then they will
      be switched off to the alternate treatment (placebo or Olivomed capsules) for another 3
      months
    
  